Sweden · Delayed Price · Currency is SEK Bergman & Beving AB Earnings Call Transcripts
Fiscal Year 2026
-
Earnings, margins, and returns improved with 4% organic growth and a 10.7% EBITDA margin, despite a -1% top-line decline due to currency and divestments. Eight acquisitions, mainly in the U.K., boosted annual revenue, while segment performance was mixed but showed strong margin gains in Core Solutions and Safety Technology.
-
Turnover reached SEK 1,127 million with EBITDA up 11% and margins improving to 11.8%. Despite sluggish core markets, profit and working capital efficiency rose, supported by acquisitions and divestments. Group targets are delayed but acquisition capacity and pipeline remain strong.
-
EBITDA rose 9% year-over-year despite a slight organic sales decline, with margin improvement and strong acquisition activity. The divestment of Skydda Nordic will delay EBITDA targets, and no organic growth is expected until year-end.
Fiscal Year 2025
-
A disciplined acquirer of niche technology companies, the group has improved margins by phasing out low-profit business and focusing on high-return acquisitions. With a strong balance sheet and clear growth targets, it is positioned for continued expansion and margin improvement.
-
Earnings, profitability, and EPS rose year-over-year, driven by acquisitions and efficiency gains, despite a weak Nordic market. The group agreed to divest Skydda Nordic, expects continued sluggishness, and maintains its acquisition strategy and financial targets.
-
Q3 delivered higher earnings, a 10% EBITDA increase, and strong cash flow, driven by acquisitions and cost control, despite a sluggish Nordic market. Four high-margin acquisitions were completed, and targets for profit and margin improvements remain on track. Market recovery is expected after summer 2024.
-
Earnings, profitability, and EPS rose in Q2, with all divisions contributing to profit growth. Despite a 3% organic revenue decline, acquisitions and efficiency measures drove margin improvements, and management remains focused on targets and preparing for a market recovery in 2025.
-
Q1 delivered higher profitability and cash flow, with EBITDA up 13% and gross margin at 47.4%. Organic growth declined 7% amid weak markets, but acquisitions and efficiency measures drove margin gains. Management remains confident in meeting 2025-26 targets.